---
title: "Craig-Hallum Reaffirms Their Buy Rating on Palvella Therapeutics (PVLA)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290447490.md"
description: "Craig-Hallum analyst Albert Lowe reaffirmed a Buy rating on Palvella Therapeutics (PVLA) with a $205 price target. Lowe, a 4-star analyst in the Healthcare sector, maintains this stance alongside an overall Strong Buy consensus for PVLA, which has an average price target of $231.90."
datetime: "2026-06-22T13:45:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290447490.md)
  - [en](https://longbridge.com/en/news/290447490.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290447490.md)
generator: "portal-rs"
---

# Craig-Hallum Reaffirms Their Buy Rating on Palvella Therapeutics (PVLA)

Craig-Hallum analyst Albert Lowe reiterated a Buy rating on Palvella Therapeutics today and set a price target of $205.00.

### TipRanks' Prime Week Sale - 70% Off

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

According to TipRanks, Lowe is a 4-star analyst with an average return of 7.8% and a 41.90% success rate. Lowe covers the Healthcare sector, focusing on stocks such as Compass Therapeutics, Neurogene, and Cardiff Oncology.

Currently, the analyst consensus on Palvella Therapeutics is a Strong Buy with an average price target of $231.90.

### Related Stocks

- [PVLA.US](https://longbridge.com/en/quote/PVLA.US.md)
- [CMPX.US](https://longbridge.com/en/quote/CMPX.US.md)
- [NGNE.US](https://longbridge.com/en/quote/NGNE.US.md)
- [CRDF.US](https://longbridge.com/en/quote/CRDF.US.md)

## Related News & Research

- [Primecap Management Co. CA Makes New Investment in Palvella Therapeutics, Inc. $PVLA](https://longbridge.com/en/news/297156499.md)
- [Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Spyre Therapeutics (SYRE)](https://longbridge.com/en/news/297408646.md)
- [Alliance Global Partners Sticks to Their Buy Rating for Pelthos Therapeutics (PTHS)](https://longbridge.com/en/news/297544479.md)
- [Akebia Therapeutics holds investor meetings at Wells Fargo Healthcare Conference](https://longbridge.com/en/news/297649009.md)
- [enGene Therapeutics to Present at Wells Fargo Healthcare Conference](https://longbridge.com/en/news/297652876.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**